Literature DB >> 10695480

Structure and function of the urokinase receptor.

A Mondino1, M Resnati, F Blasi.   

Abstract

The binding of the urokinase plasminogen activator (uPA) to its receptor (uPAR) regulates cell adhesion, surface proteolysis, chemotaxis and cell extravasation in a number of experimental systems. Recent evidences have suggested that uPAR can by itself mediate chemotaxis of human monocytes and cause profound changes in cytoskeletal organization indicating that this receptor has the properties of a cell-surface regulated chemokine. Indeed, it is likely that upon binding to uPA, uPAR undergoes a conformational change that uncovers a new epitope located in the linker region between domain 1 and 2 of the receptor and is endowed with a potent chemotactic activity. This conformational change can be mimicked in vitro by enzymatic processing of a recombinant receptor. We have shown that chymotrypsin cleaves uPAR between domain 1 and 2 in an area that can be also cleaved by uPA at high efficiency and generate a receptor that can mediate monocytes migration independently of uPA binding. This mechanism is pertussis-toxin sensitive and involves activation of tyrosine kinases and cytoskeletal reorganization events in vitro. These studies indicate that in addition to its receptor function, upon binding to uPA, uPAR becomes a pleiotropic ligand for other still to be identified surface molecules.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10695480

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  16 in total

1.  Differential expression of Plg-RKT and its effects on migration of proinflammatory monocyte and macrophage subsets.

Authors:  Barbara Thaler; Nagyung Baik; Philipp J Hohensinner; Johanna Baumgartner; Adelheid Panzenböck; Stefan Stojkovic; Svitlana Demyanets; Ihor Huk; Gersina Rega-Kaun; Christoph Kaun; Manfred Prager; Michael B Fischer; Kurt Huber; Walter S Speidl; Robert J Parmer; Lindsey A Miles; Johann Wojta
Journal:  Blood       Date:  2019-06-20       Impact factor: 22.113

2.  Urokinase-type plasminogen activator modulates airway eosinophil adhesion in asthma.

Authors:  Anne M Brooks; Mary Ellen Bates; Rose F Vrtis; Nizar N Jarjour; Paul J Bertics; Julie B Sedgwick
Journal:  Am J Respir Cell Mol Biol       Date:  2006-05-25       Impact factor: 6.914

3.  Changes induced in colonocytes by extensive intestinal resection in rats.

Authors:  Hubert Lardy; Muriel Thomas; Marie-Louise Noordine; Aurélia Bruneau; Claire Cherbuy; Pierre Vaugelade; Catherine Philippe; Virginie Colomb; Pierre-Henri Duee
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

4.  Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush.

Authors:  L B Siconolfi; N W Seeds
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

5.  Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells.

Authors:  Sumaira Amir; Naira V Margaryan; Valerie Odero-Marah; Zhila Khalkhali-Ellis; Mary J C Hendrix
Journal:  Cancer Biol Ther       Date:  2005-04-21       Impact factor: 4.742

6.  Association between urokinase haplotypes and outcome from infection-associated acute lung injury.

Authors:  John Arcaroli; Jeff Sankoff; Nianjun Liu; David B Allison; James Maloney; Edward Abraham
Journal:  Intensive Care Med       Date:  2007-11-10       Impact factor: 17.440

7.  Vitamin D3 modulation of plasminogen activator inhibitor type-1 in human breast carcinomas under organ culture.

Authors:  Edson Mantovani Barbosa; Sueli Nonogaki; Maria Lucia Hirata Katayama; Maria Aparecida Azevedo Koike Folgueira; Venâncio Ferreira Avancini Alves; Maria Mitzi Brentani
Journal:  Virchows Arch       Date:  2003-12-02       Impact factor: 4.064

8.  A deletion mutant of vitronectin lacking the somatomedin B domain exhibits residual plasminogen activator inhibitor-1-binding activity.

Authors:  Christine R Schar; Grant E Blouse; Kenneth H Minor; Cynthia B Peterson
Journal:  J Biol Chem       Date:  2008-01-03       Impact factor: 5.157

9.  Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism.

Authors:  Ralf-Peter Czekay; David J Loskutoff
Journal:  J Cell Physiol       Date:  2009-09       Impact factor: 6.384

10.  Inhibitory effects of retinoic acid on invasiveness of human thyroid carcinoma cell lines in vitro.

Authors:  L Lan; D Cui; Y Luo; B Y Shi; L L Deng; G Y Zhang; H Wang
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.